Patient | Age/Sex | DQ2/8 variant | Modified MARSH grade | Celiac disease | Group | Diagnosis/diet (months) | Anti-Transglutaminasea | CD familiarity |
---|---|---|---|---|---|---|---|---|
 |  |  |  | CD patients |  |  |  | |
Patient 1 | 26/M | -b | 0 | Excluded | Group A | 0/0 | −/− |  |
Patient 2 | 42/F | - | 0 | Excluded | Group A | 0/0 | −/− |  |
Patient 3 | 16/F | DQ2 | 0 | Excluded | Group A | 0/0 | −/− |  |
Patient 4 | 19/F | - | 0 | Excluded | Group A | 0/0 | 31/− | yes |
Patient 5 | 59/F | DQ2 | 0 | Excluded | Group A | 0/0 | 31/− |  |
Patient 6 | 25/M | - | 0 | Excluded | Group A | 0/0 | 37/− |  |
Patient 7 | 34/F | - | 0 | Excluded | Group A | 0/0 | 52/− |  |
Patient 8 | 44/M | DQ2 | 0 | Suspectedc | Group A | 36/36 | −/− |  |
Patient 9 | 46/M | DQ2 | 0 | Suspectedd | Group A | 0/0 | −/7.5 |  |
Patient 10 | 39/F | DQ2 | 0 | Confirmed | Group A | 0/0 | −/16 |  |
Patient 11 | 22/F | DQ2 | 0 | Confirmed | Group A | 0/0 | −/73 | yes |
Patient 12 | 47/F | DQ2 | I | Confirmed | Group A | 60/58 | −/− |  |
Patient 13 | 34/M | DQ2 | I | Confirmed | Group A | 25/24 | −/08 |  |
Patient 14 | 39/F | DQ2 | II | Confirmed | Group B | 0/0 | 26/16 | Â |
Patient 15 | 52/M | DQ2 | III A | Confirmed | Group B | 0/0 | −/15 |  |
Patient 16 | 36/M | DQ2 | III B | Confirmed | Group B | 0/0 | 26/20 | Â |
Patient 17 | 41/M | DQ2 | III B | Confirmed | Group B | 0/0 | −/21 |  |
Patient 18 | 38/F | DQ2 | III A | Confirmed | Group B | 0/0 | 130/NEe | Â |
Patient 19 | 33/F | DQ2 | III A | Confirmed | Group B | 0/0 | 336/NE | Â |
 |  |  |  | Refractory CD patients |  |  |  | |
Patient 20 | 32/F | DQ2 | III B | Confirmed |  | 96/72 | −/− | yes |
Patient 21 | 29/F | DQ8 | III A | Confirmed |  | 12/12 | −/− |  |
Patient 22 | 43/F | DQ2 | III A | Confirmed |  | 120/118 | −/− |  |
Patient 23 | 41/M | DQ2 | III A | Confirmed |  | 240/238 | −/− |  |
Patient 24 | 32/F | DQ2 and DQ8 | III A | Confirmed | Â | 60/57 | 400/400 | Â |